Relmada Therapeutics, Inc. (RLMD)
NASDAQ: RLMD · Real-Time Price · USD
4.160
-0.270 (-6.09%)
At close: Nov 12, 2026, 4:00 PM EST
4.720
+0.560 (13.46%)
After-hours: Nov 12, 2026, 7:50 PM EST
Relmada Therapeutics Employees
Relmada Therapeutics had 17 employees as of December 31, 2025. The number of employees did not change compared to the previous year. That makes Relmada Therapeutics the 38,909th largest employer in the world and 5,646th in the United States.
Employees
17
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-$3,864,476
Market Cap
443.75M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 17 | 0 | - |
| Dec 31, 2024 | 17 | -3 | -15.00% |
| Dec 31, 2023 | 20 | 6 | 42.86% |
| Dec 31, 2022 | 14 | 4 | 40.00% |
| Dec 31, 2021 | 10 | -4 | -28.57% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| MiMedx Group | 808 |
| Gyre Therapeutics | 625 |
| Arvinas | 246 |
| Orchestra BioMed Holdings | 86 |
| Assembly Biosciences | 73 |
| CytomX Therapeutics | 69 |
| Prothena Corporation | 67 |
| Oculis Holding AG | 60 |
RLMD News
- 10 hours ago - Relmada Therapeutics Earnings Call Transcript: Q3 2026 - Transcripts
- 10 hours ago - Relmada Therapeutics Quarterly report: Q3 2026 - Filings
- 10 hours ago - Relmada Therapeutics Earnings release: Q3 2026 - Filings
- 11 hours ago - Relmada Therapeutics Reports Third Quarter 2026 Financial Results and Provides Business Update - GlobeNewsWire
- 8 days ago - Relmada Therapeutics to Participate at the Jefferies Global Healthcare Conference in London - GlobeNewsWire
- 9 days ago - Relmada Therapeutics to Report Third Quarter 2026 Financial Results on Thursday, November 12, 2026 - GlobeNewsWire
- 2 months ago - Relmada Therapeutics to Participate at the Wells Fargo 21st Annual Healthcare Conference - GlobeNewsWire
- 3 months ago - Relmada Therapeutics reports Q2 EPS (11c), consensus (20c) - TheFly